Lilly’s stock tumbled as disappointing trial data for an oral weight-loss pill offset an upbeat earnings report and outlook.
www.marketwatch.com
#Eli #Lillys #weightloss #pill #didnt #work #stock #plunging
BigBear.ai Holdings, Inc. (NYSE:BBAI) is one of the 25 stocks Jim Cramer recently shared insights on. When a caller mentioned…
The Food and Drug Administration will consider drug affordability when granting companies new vouchers that speed up approvals of some…
(Reuters) -Chinese electric vehicle brands Neta and Zeekr inflated sales in recent years to hit aggressive targets, with Neta doing…
